Altering the Proclivity towards Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Using Combinations with Other Antibiotics

Daptomycin (DAP) is increasingly used as a part of combination therapy, particularly in complex methicillin-resistant Staphylococcus aureus (MRSA) infections. While multiple studies have reported the potential for synergy between DAP and adjunctive anti-infectives, few have examined the influence of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Berti, Andrew D., Wergin, Justine E., Girdaukas, Gary G., Hetzel, Scott J., Sakoulas, George, Rose, Warren E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2012
Gaiak:
Experimental Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3457407/
https://ncbi.nlm.nih.gov/pubmed/22802248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00502-12
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak